A Phase II trial of temozolomide and BCNU [carmustine] for anaplastic gliomas
Phase of Trial: Phase II
Latest Information Update: 05 Jul 2018
At a glance
- Drugs Carmustine (Primary) ; Temozolomide (Primary)
- Indications Anaplastic astrocytoma; Glioblastoma; Glioma
- Focus Therapeutic Use
- 25 Jun 2018 Status changed from active, no longer recruiting to completed.
- 20 Sep 2005 New trial record.